Marc Pelletier

Marc Pelletier

Company: Novartis

Job title: Translational Immuno-Oncology


Lessons Learned & Looking Beyond – Novartis’ Journey with TGF-β 9:10 am

First-in-human data – from biomarker and clinical outcomes Potential insights into patient selection What did we learn from other studies so far and how does this inform Ph2+ design?Read more

day: Day Two

© Copyright 2018 Hanson Wade | Design and site by Event Engine | Hanson Wade Limited is registered in England & Wales, number 06752216.
Registered Office: Suite A, 6 Honduras Street, London EC1Y 0TH.